Gideon Berke Professor Gideon Berke
The Isaac and Elsa Bourla Professor of Cancer Research

 List of Publications (last 3 years)

  1. Berke, G.(1998). Cancer immune surveillance, In: The Biotherapy of Cancers: From Immunotherapy to Gene Therapy (Chouaib, S. ed.), Inserm press, pp. 173-185.
  2. Felzen, B., Shilkrut, M., Less, H., Sarapov, I., Coleman, R., Robinson, R.B., Berke, G. and Binah, O. (1998). Fas(CD95/APO1)-mediated damage to ventricular myocytes induced by Cytotoxic T Lymphocytes from perforin deficient mice: A major role for inositol 1,4,5 tri-phosphate. Circulation Res., 82: 438-450.
  3. Tsotsiashvili, M., Levi, R., Arnon, R. and Berke, G. (1998). Activation of influenza-specific cytotoxic T lymphocytes by Concanavalin A stimulation. Immunol. Letts., 60: 89-95.
  4. Li, J-H., Rosen, D., Ronen, D., Behrens, C.K., Krammer, P.H., Clark, W.R. and Berke, G. (1998). The regulation of CD95 ligand expression and function in CTL. J.Immunol., 161: 3943-3949.
  5. Less, H., Shilkrut, M., Rubinstein, I., Berke, G. and Binah, O. (1999). Cardiac dysfunction in murine autoimmune myocarditis. J. Autoimmunity, 12: 209-220.
  6. Deutsch, M., Zurgil, N., Kaufman, M. and Berke, G. (2000). Fluorescence polarization as an early measure of T Cell stimulation. In: T Cell Protocols: Development and Activation (Kearse, K.P. ed.), Human Press, Totowa, NJ. Methods Mol. Biol. 134: 221-242.
  7. Rosen, D., Li, J.H., Keidar, S., Markon, I., Orda, R. and Berke, G. (2000). Tumor immunity in perforin-deficient mice: A Role for CD95(Fas/APO-1). J. Immunol., 164: 3229-3235.
  8. Shilkrut, M., Gealekman, O., Rosen, D., Berke, G., Woodcock, E. and Binah, O. (2001). Electrophysiological perturbations and arrhythmogenic activity caused by activation of the Fas receptor in murine ventricular myocytes: The role of the inositol triphosphate pathway. J. Cardiovascular Electrophysiology, 12: 185-195.
  9. Li, J-H., Rosen, D., Sondel, P. and Berke, G. (2002). Immune privilege and FasL: Two ways to inactivate effector CTLs by FasL expressing cells. Immunology. (in press).
  10. Berke, G., Krutovskikh, V. and Yamasaki H. (2002). Is mutated connexin 37 the origin of the MUT 1 and 2 octapeptides reported to be shared tumor-associated antigens of lung carcinomas 3LL and CMT? (submitted).
  11. Schiffenbauer, Y. S., Trubniykov, E., Zacharia, B-T., Gerbat, S., Rehavi, Z., Berke, G. and Chaitchik, S. (2002). Tumor sensitivity to anti-cancer drugs predicted by changes in fluorescence intensity and polarization in vitro. (submitted).
  12. Yaniv, G., Shilkrut, M., Maor, G., Lotan, R., Sarit, L-B., Berke, G., Binah, O. (2002). Activation of the Fas receptor causes apoptosis in ischemic but not in normoxic neonatal rat ventricular myocytes. (submitted).
  13. Cohen, C. J., Denkberg, G., Segal, D., Schiffenbauer, Y., Trubniyakov, E., Berke, G. and Reiter, Y. (2002). Activation of Tumor-specific T cells by peptide-MHC complexes demonstrated at the single cell level. (submitted).
  14. Li, J-H., Sondel, P. and Berke, G. (2002). FasL expressing leukemia cells undergo fratricide following Fas upregulation in vivo. (in preparation).
  15. Berke, G. and Clark, W. The killer lymphocyte Kluwer press. (in preparation).

 Complete List of Publications